Home Cart Sign in  
Chemical Structure| 280744-09-4 Chemical Structure| 280744-09-4

Structure of SB-216763
CAS No.: 280744-09-4

Chemical Structure| 280744-09-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SB 216763 is a potent, selective, and ATP-competitive GSK-3 inhibitor with IC50s of 34.3 nM for both GSK-3α and GSK-3β.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SB-216763

CAS No. :280744-09-4
Formula : C19H12Cl2N2O2
M.W : 371.22
SMILES Code : O=C(C(C1=CC=C(Cl)C=C1Cl)=C2C3=CN(C)C4=C3C=CC=C4)NC2=O
MDL No. :MFCD09753369
InChI Key :JCSGFHVFHSKIJH-UHFFFAOYSA-N
Pubchem ID :176158

Safety of SB-216763

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SB-216763

PI3K-AKT
Hedgehog

Isoform Comparison

Biological Activity

Target
  • GSK-3α

    GSK-3α, IC50:34.3 nM

  • GSK-3β

    GSK-3β, IC50:~34.3 nM

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Diabetes model Tail intravenous injection 600 µg/kg Every 2 days for 2 months Inhibition of GSK-3β activity completely prevented diabetes-induced glycogen synthase phosphorylation, HK II downregulation, PPARα upregulation, PGC-1 downregulation, and lipid accumulation in the heart of the wild-type diabetic mice. PMC2682666
Mice TMEM43 mutant mouse model Intraperitoneal injection 2.5 mg/kg Daily To study the effect of SB-216763 on cardiac function in TMEM43 mutant mice, results showed that SB-216763 improved cardiac function and reduced cardiomyocyte death. PMC6784777
Mice LRP6+/− mice Intraperitoneal injection 1 mg/kg 16 hours SB-216763 inhibited GSK-3β activity and reversed the increased Ca2+-induced depolarization in LRP6+/? mice mitochondria PMC3933931
Mice Df(16)A+/− mouse model Intraperitoneal injection 2 mg/kg Every other day, from P7 to P28 Developmental inhibition of Gsk3 rescues deficits in hippocampal-prefrontal connectivity, task-related neural activity, and spatial working memory behavior in Df(16)A+/? mice. PMC4783174
Mice Wild-type C57BL/6 mice Intraperitoneal injection 1-10 mg/kg Single dose, 10 minutes prior to NOR task training To investigate the role of GSK3 in the NOR task, results showed that SB216763-treated mice exhibited impaired performance in the NOR task and recognition memory. PMC6942274
Mice Bilateral renal ischemia-reperfusion injury model Intraperitoneal injection 20 mg/kg Single dose, lasting 14 days GSK3 inhibition alleviated bilateral IR-induced renal fibrosis and renal function impairment. PMC5519017
Mice Adult mice Intraperitoneal injection 2 mg/kg Every other day for 2 weeks SB-216763 treatment significantly increased the number of BrdU positive cells and rescued the reduction in BrdU positive cells caused by DISC1 knockdown PMC2704382

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.69mL

0.54mL

0.27mL

13.47mL

2.69mL

1.35mL

26.94mL

5.39mL

2.69mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories